Friedman, Daphne R <br/><br/>
A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2009 
 - 6947-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-09-1132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--pharmacology<br/>Chlorambucil--pharmacology<br/>Cyclophosphamide--pharmacology<br/>Disease Progression<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Genomics--methods<br/>Humans<br/>Immunotherapy--methods<br/>Leukemia, Lymphocytic, Chronic, B-Cell--genetics<br/>Male<br/>Middle Aged<br/>Pentostatin--pharmacology<br/>Pharmacogenetics--methods<br/>Prognosis<br/>Risk<br/>Rituximab